{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:46:09Z","timestamp":1792320369725,"version":"4.4.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-025-01377-8","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T08:39:59Z","timestamp":1769675999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pancreatic Mucinous Cystic Neoplasms Following GLP-1 Receptor Agonists Use: A Report of Two Cases with Literature Review"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-3117","authenticated-orcid":false,"given":"Nourah Mohammed","family":"Alsaleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad","family":"Abo Alshamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wejdan","family":"Almrzouqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alhebshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turky","family":"Aljuhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahf","family":"Almahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Almaghrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almotasembillah","family":"Rammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Ageel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ahmad","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"1377_CR1","doi-asserted-by":"publisher","first-page":"645563","DOI":"10.3389\/fendo.2021.645563","volume":"12","author":"MM Smits","year":"2021","unstructured":"Smits MM, van Raalte DH. Safety of semaglutide. Front Endocrinol (Lausanne). 2021;12:645563. https:\/\/doi.org\/10.3389\/fendo.2021.645563 .\u00a0[PMID: PMC8294388].","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1377_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s43440-024-00629-x","volume":"76","author":"M Tobaiqy","year":"2024","unstructured":"Tobaiqy M. A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment. Pharmacol Rep. 2024;76(5):981\u201390. https:\/\/doi.org\/10.1007\/s43440-024-00629-x . [PMID: 39093550].","journal-title":"Pharmacol Rep"},{"issue":"5","key":"1377_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamainternmed.2022.0338","volume":"182","author":"L He","year":"2022","unstructured":"He L, Wang J, Ping F, et al. Association of Glucagon-Like Peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: A systematic review and Meta-analysis of randomized clinical trials. JAMA Intern Med. 2022;182(5):513\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2022.0338 . [PMID: PMC8961394].","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1377_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.endien.2024.03.012","volume":"71","author":"W Masson","year":"2024","unstructured":"Masson W, Lobo M, Barbagelata L, Lavalle-Cobo A, Nogueira JP. Acute pancreatitis due to different semaglutide regimens: an updated meta-analysis. Endocrinol Diabetes Nutr (Engl Ed). 2024;71(3):124\u201332. https:\/\/doi.org\/10.1016\/j.endien.2024.03.012 . [PMID: 38555109].","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"1377_CR5","doi-asserted-by":"publisher","unstructured":"Guo H, Guo Q, Li Z, Wang Z. Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis. Front Pharmacol. 2024;15:1461398. https:\/\/doi.org\/10.3389\/fphar.2024.1461398 . [PMID: PMC11600108].","DOI":"10.3389\/fphar.2024.1461398"},{"issue":"3","key":"1377_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/endocrines5030023","volume":"5","author":"P Sharma","year":"2024","unstructured":"Sharma P, Buddhavarapu V, Dhillon G, Verma RK, Devadoss R, Raynor J, Munjal R, Grewal H, Kashyap R. Glucagon-like Peptide-1 receptor agonists: are they as good as they seem? A systematic review of severe adverse effects. Endocrines. 2024;5(3):323\u201333. https:\/\/doi.org\/10.3390\/endocrines5030023.","journal-title":"Endocrines"},{"issue":"3","key":"1377_CR7","doi-asserted-by":"publisher","first-page":"e55549","DOI":"10.7759\/cureus.55549","volume":"16","author":"C Agra de Melo Junior","year":"2024","unstructured":"Agra de Melo Junior C, Gomes J\u00fanior NE, da Silva Ribeiro-Sousa MA, Cunha SFC. Exocrine pancreatic insufficiency during the use of semaglutide: A case report. Cureus. 2024;16(3):e55549. https:\/\/doi.org\/10.7759\/cureus.55549 . [PMID: PMC10993639].","journal-title":"Cureus"},{"key":"1377_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","volume":"84","author":"RA Agha","year":"2020","unstructured":"Agha RA, Franchi T, Sohrabi C, Mathew G, Kerwan A, SCARE Group. The SCARE 2020 guideline: updating consensus surgical case report (SCARE) guidelines. Int J Surg. 2020;84:226\u201330. https:\/\/doi.org\/10.1016\/j.ijsu.2020.10.034 . [PMID: 33181358].","journal-title":"Int J Surg"},{"issue":"3","key":"1377_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11096-023-01556-2","volume":"45","author":"M Cao","year":"2023","unstructured":"Cao M, Pan C, Tian Y, Wang L, Zhao Z, Zhu B. Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA adverse event reporting system and literature visualization analysis. Int J Clin Pharm. 2023;45(3):689\u201397. https:\/\/doi.org\/10.1007\/s11096-023-01556-2 . [PMID: 36977858].","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"1377_CR10","doi-asserted-by":"publisher","first-page":"e43773","DOI":"10.1016\/j.ijsu.2020.10.034","volume":"15","author":"F Patel","year":"2023","unstructured":"Patel F, Gan A, Chang K, Vega KJ. Acute pancreatitis in a patient taking semaglutide. Cureus. 2023;15(8):e43773. https:\/\/doi.org\/10.1016\/j.ijsu.2020.10.034 . [PMID: PMC10506915].","journal-title":"Cureus"},{"issue":"10","key":"1377_CR11","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.7759\/cureus.47559","volume":"15","author":"MM Raza","year":"2023","unstructured":"Raza MM, Logan MR, Stuart DL, Patel H. Atypical presentation of a preexisting pancreatic pseudocyst with glucagon\u2013like peptide\u20131 agonist as a possible trigger for exacerbation: a case report. Cureus. 2023;15(10):e47559. https:\/\/doi.org\/10.7759\/cureus.47559 . [PMID: PMC].","journal-title":"Cureus"},{"issue":"1","key":"1377_CR12","doi-asserted-by":"publisher","first-page":"e2350408","DOI":"10.1001\/jamanetworkopen.2023.50408","volume":"7","author":"R Dankner","year":"2024","unstructured":"Dankner R, Murad H, Agay N, Olmer L, Freedman LS. Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk in patients with type 2 diabetes. JAMA Netw Open. 2024;7(1):e2350408. [Pubmed: 38175642]. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.50408 [PMID: PMC10767614].","journal-title":"JAMA Netw Open"},{"issue":"9","key":"1377_CR13","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/cancers16091625","volume":"16","author":"M Ayoub","year":"2024","unstructured":"Ayoub M, Faris C, Juranovic T, Chela H, Daglilar E. The use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus does not increase the risk of pancreatic cancer: a U.S.-based cohort study. Cancers (Basel). 2024;16(9):1625. https:\/\/doi.org\/10.3390\/cancers16091625 [PMID: PMC11082986].","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01377-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01377-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01377-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T08:40:01Z","timestamp":1769676001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01377-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01377-8","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"11 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was reviewed and approved by the institutional ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from both patients for publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not commissioned, externally peer-reviewed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Provenance and Peer Review"}},{"value":"Dr. Alsaleh accepts full responsibility for the work and the integrity of the report.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Both patients reported satisfaction with their outcomes and remained asymptomatic at follow-up.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Perspective"}}],"article-number":"28"}}